BBIO
BridgeBio Pharma Inc
NASDAQ: BBIO · HEALTHCARE · BIOTECHNOLOGY
$70.94
+1.76% today
Updated 2026-04-29
Market cap
$13.75B
P/E ratio
—
P/S ratio
27.39x
EPS (TTM)
$-3.78
Dividend yield
—
52W range
$32 – $85
Volume
2.5M
BridgeBio Pharma Inc (BBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-19.2%
Last 4 quarters
Revenue YoY growth
+2521.2%
Most recent quarter
EPS YoY growth
+31.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.2%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-7.8%
2026-02-19
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $-0.94 | -31.1% | $73.93 | $68.14 | -7.8% |
| 2025-10-29 | $-0.95 | -8.0% | $64.50 | $63.37 | -1.8% |
| 2025-08-05 | $-0.95 | -26.7% | $47.75 | $44.81 | -6.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.72 | $-0.94 | -31.1% | $154.18M | +2521.2% |
| 2025-09-30 | $-0.88 | $-0.95 | -8.0% | $120.70M | +4318.0% |
| 2025-06-30 | $-0.75 | $-0.95 | -26.7% | $110.56M | +4999.9% |
| 2025-03-31 | $-0.89 | $-0.99 | -11.1% | $116.63M | -44.8% |
| 2024-12-31 | $-1.09 | $-1.37 | -26.1% | $5.88M | +237.1% |
| 2024-09-30 | $-0.98 | $-0.86 | +12.3% | $2.73M | -33.2% |
| 2024-06-30 | $-1.06 | $-0.39 | +63.2% | $2.17M | +32.1% |
| 2024-03-31 | $-0.71 | $-0.20 | +71.8% | $211.12M | — |
| 2023-12-31 | $-0.91 | $-0.96 | -5.5% | $1.75M | — |
| 2023-09-30 | $-0.82 | $-1.08 | -31.7% | $4.09M | — |
| 2023-06-30 | $-0.83 | $-0.98 | -18.1% | $1.64M | — |
Frequently asked questions
Has BridgeBio Pharma Inc beaten earnings estimates?
BridgeBio Pharma Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -19.2% over the last 4 quarters.
How does BBIO stock react to earnings?
BBIO stock has moved an average of -5.2% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is BridgeBio Pharma Inc's revenue growth rate?
BridgeBio Pharma Inc reported year-over-year revenue growth of +2521.2% in its most recent quarter, with EPS growing +31.7% year-over-year.